DE:ANW Stock Latest News
Company AnnouncementsImmuron CEO to showcase infectious-disease portfolio at Emerging Growth Conference3w ago
Company AnnouncementsImmuron trims ATM facility to US$2 million while preserving funding flexibility3w ago
Company AnnouncementsImmuron lifts Q1 sales on Travelan surge despite U.S. softness3w ago
Company AnnouncementsImmuron CEO to Spotlight Oral Antibody Platform at Emerging Growth Conference1M ago
Company AnnouncementsImmuron Releases Comprehensive 2026 Annual Report1M ago
Company AnnouncementsImmuron Showcases Oral Antibody Platform at Coffee Microcaps Conference2M ago
The FlyImmuron to launch Proibs in the U.S.2M agoIMRN
Company AnnouncementsImmuron to Launch Calmino’s Digestive Health Device PROIBS in U.S. Market2M ago
Company AnnouncementsImmuron Issues FY26 Preliminary Results With Safe Harbor Caution2M agoCompany AnnouncementsImmuron CEO to Spotlight Oral Immunotherapy Portfolio at Emerging Growth Conference3M ago
Company AnnouncementsImmuron CEO Showcases Gut-Targeted Antibody Platform at TechKnow Invest Roadshow3M ago
Company AnnouncementsImmuron Seeks Transformational Partnership for C. difficile Drug IMM-5294M ago
Company AnnouncementsImmuron Adjusts Capital Structure as Over 3.8 Million Shares Cease4M ago
Company AnnouncementsImmuron Options Lapse, Trimming Potential Dilution in Capital Structure5M ago
Company AnnouncementsImmuron Says No Undisclosed News Behind Share Price Spike5M agoCompany AnnouncementsImmuron CEO to Spotlight Antibody-Based GI Portfolio at Emerging Growth Conference6M ago






